| 来源类型 | Working Paper |
| 规范类型 | 报告 |
| DOI | 10.3386/w17943 |
| 来源ID | Working Paper 17943 |
| Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial | |
| Jessica Cohen; Pascaline Dupas; Simone G. Schaner | |
| 发表日期 | 2012-03-29 |
| 出版年 | 2012 |
| 语种 | 英语 |
| 摘要 | Both under- and over-treatment of communicable diseases are public bads. But efforts to decrease one run the risk of increasing the other. Using rich experimental data on household treatment-seeking behavior in Kenya, we study the implications of this tradeoff for subsidizing life-saving antimalarials sold over-the-counter at retail drug outlets. We show that a very high subsidy (such as the one under consideration by the international community) dramatically increases access, but nearly half of subsidized pills go to patients without malaria. We study two ways to better target subsidized drugs: reducing the subsidy level and introducing rapid malaria tests over-the-counter. |
| 主题 | Microeconomics ; Welfare and Collective Choice ; Public Economics ; Taxation ; Health, Education, and Welfare ; Health ; Development and Growth ; Development |
| URL | https://www.nber.org/papers/w17943 |
| 来源智库 | National Bureau of Economic Research (United States) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/575619 |
| 推荐引用方式 GB/T 7714 | Jessica Cohen,Pascaline Dupas,Simone G. Schaner. Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial. 2012. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 资源类型 | 版本类型 | 开放类型 | 使用许可 | ||
| w17943.pdf（944KB） | 智库出版物 | 限制开放 | CC BY-NC-SA | 浏览 | ||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
